Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.04 Billion CNY | -13.66% |
| 2022 | 1.2 Billion CNY | 60.51% |
| 2021 | 753.08 Million CNY | -16.75% |
| 2020 | 904.62 Million CNY | 0.9% |
| 2019 | 896.58 Million CNY | 34.56% |
| 2018 | 666.3 Million CNY | 31.51% |
| 2017 | 506.67 Million CNY | 25.91% |
| 2016 | 402.4 Million CNY | 52.49% |
| 2015 | 263.88 Million CNY | 19.83% |
| 2014 | 220.21 Million CNY | 18.42% |
| 2013 | 185.95 Million CNY | 35.66% |
| 2012 | 137.07 Million CNY | 25.08% |
| 2011 | 109.59 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 203.84 Million CNY | -43.39% |
| 2024 Q3 | 338.89 Million CNY | 42.74% |
| 2024 Q1 | 360.06 Million CNY | 78.56% |
| 2023 Q3 | 296.3 Million CNY | 25.1% |
| 2023 Q1 | 308.86 Million CNY | 65.89% |
| 2023 Q2 | 236.86 Million CNY | -23.31% |
| 2023 Q4 | 201.64 Million CNY | -31.95% |
| 2023 FY | 1.04 Billion CNY | -13.66% |
| 2022 Q3 | 255.04 Million CNY | 43.23% |
| 2022 Q1 | 270.77 Million CNY | 75.81% |
| 2022 FY | 1.2 Billion CNY | 60.51% |
| 2022 Q4 | 186.18 Million CNY | -27.0% |
| 2022 Q2 | 178.05 Million CNY | -34.24% |
| 2021 Q3 | 213.46 Million CNY | 29.68% |
| 2021 Q1 | 263.48 Million CNY | 79.17% |
| 2021 FY | 753.08 Million CNY | -16.75% |
| 2021 Q2 | 164.6 Million CNY | -37.53% |
| 2021 Q4 | 154 Million CNY | -27.85% |
| 2020 Q3 | 263.06 Million CNY | 0.41% |
| 2020 Q4 | 147.05 Million CNY | -44.1% |
| 2020 FY | 904.62 Million CNY | 0.9% |
| 2020 Q1 | 232.51 Million CNY | 24.13% |
| 2020 Q2 | 261.99 Million CNY | 12.68% |
| 2019 Q3 | 248.26 Million CNY | -6.32% |
| 2019 Q2 | 265.02 Million CNY | 35.23% |
| 2019 Q1 | 195.98 Million CNY | 8.38% |
| 2019 FY | 896.58 Million CNY | 34.56% |
| 2019 Q4 | 187.31 Million CNY | -24.55% |
| 2018 Q4 | 180.83 Million CNY | 7.28% |
| 2018 Q3 | 168.55 Million CNY | -5.01% |
| 2018 FY | 666.3 Million CNY | 31.51% |
| 2018 Q2 | 177.44 Million CNY | 27.23% |
| 2018 Q1 | 139.47 Million CNY | 0.2% |
| 2017 Q2 | 138.02 Million CNY | 31.28% |
| 2017 Q4 | 139.19 Million CNY | 11.96% |
| 2017 FY | 506.67 Million CNY | 25.91% |
| 2017 Q1 | 105.13 Million CNY | -7.78% |
| 2017 Q3 | 124.32 Million CNY | -9.93% |
| 2016 Q3 | 101.91 Million CNY | -4.99% |
| 2016 FY | 402.4 Million CNY | 52.49% |
| 2016 Q4 | 114 Million CNY | 11.86% |
| 2016 Q2 | 107.26 Million CNY | 35.39% |
| 2016 Q1 | 79.22 Million CNY | 24.53% |
| 2015 Q3 | 74.54 Million CNY | 3.75% |
| 2015 FY | 263.88 Million CNY | 19.83% |
| 2015 Q1 | 53.87 Million CNY | -8.32% |
| 2015 Q2 | 71.84 Million CNY | 33.36% |
| 2015 Q4 | 63.62 Million CNY | -14.65% |
| 2014 Q3 | 55.52 Million CNY | -4.29% |
| 2014 Q4 | 58.76 Million CNY | 5.82% |
| 2014 FY | 220.21 Million CNY | 18.42% |
| 2014 Q2 | 58.01 Million CNY | 21.08% |
| 2014 Q1 | 47.91 Million CNY | 2.72% |
| 2013 Q3 | 58.28 Million CNY | 0.0% |
| 2013 FY | 185.95 Million CNY | 35.66% |
| 2013 Q4 | 46.64 Million CNY | -19.98% |
| 2012 FY | 137.07 Million CNY | 25.08% |
| 2011 FY | 109.59 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 1.67 Billion CNY | 37.591% |
| Liaoning Cheng Da Co., Ltd. | 146.51 Million CNY | -612.327% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 8.19 Billion CNY | 87.265% |